Presentation EuroPCR 2013 The Next Generation Renal Denervation Technology - The Vessix Device Presenter: E. Wyffels May 31, 2013
Presentation EuroPCR 2013 Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent Presenter: 228635|John Ormiston May 31, 2013
Presentation Prognostic Value of Stress CMR Imaging in Patients with Known or Suspected CAD Presenter: M.J. Lipinski May 31, 2013
Presentation EuroPCR 2013 One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study Presenter: 13956|Raul Moreno May 31, 2013
Presentation EuroPCR 2013 Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System Presenter: 203171|Ian Meredith May 31, 2013
Presentation Aortic Stenosis in the Elderly: Disease Prevalence and Number of Candidates for TAVR Presenter: 201433|Ruben L. J. Osnabrugge May 30, 2013
Presentation Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After TAVI Presenter: O. Husser May 29, 2013
Presentation Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy Presenter: M. Urena May 28, 2013
Presentation The Impact of Integration of a Multidetector CT Annulus Area Sizing Algorithm on TAVR Outcomes Presenter: R. K. Binder May 28, 2013
Presentation Heparin vs. Bivalirudin in Patients with NSTE-ACS Undergoing PCI Presenter: Oskar Anger?s May 23, 2013